340B Pharmacy Growth

Blog on the 340B drug program, health reform and more. Insights from a team of people working where the rubber hits the road.

Search This Blog

Monday, August 29, 2011

Medicaid’s cost conundrum - Ezra Klein - The Washington Post

Posted by Unknown at 10:01 AM

Email This BlogThis!Share to Twitter Share to Facebook Share to Pinterest

No comments:

About Me

Unknown

View my complete profile

This Blog

I am the President & CEO of Equiscript, LLC.

These are my thoughts and observations about our company, our role in improving patient care, and our industry.

Equiscript provides services to 340B eligible entities. You will find that I (and our team at Equiscript) have an inclination towards the patient experience and the important role pharmacy can - and should - play in providing great patient care and improving outcomes.

You will also find that we have a vision for bringing personal relationships back in to healthcare. Our dedication to this is included in our company tagline - Bringing Health Back Home.

Subscribe To

Posts

Atom

Posts

Comments

Atom

Comments

Useful Links

Equiscript, LLC - Our Company
HRSA Office of Pharmacy Affairs

Blog Archive

▼ 2011 (14)
- ▼ August (2)
  - Medicaid’s cost conundrum - Ezra Klein - The Washi...
  - amednews: Medicaid fetches higher drug rebates tha...
- ► February (1)
- ► January (11)

Search This Blog

Monday, August 29, 2011

Medicaid’s cost conundrum - Ezra Klein - The Washington Post

No comments:

Post a Comment